Displaying results 1 - 8 of 8
Rare Liver Diseases
EASL Policy Dialogues S3 E5: Enhancing treatment adherence & quality of life in rare liver disease

EASL Policy Dialogues S3 E5: Enhancing treatment adherence & quality of life in rare liver disease

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues S3 E4: Inspiring innovative action towards viral hepatitis elimination

EASL Policy Dialogues S3 E4: Inspiring innovative action towards viral hepatitis elimination

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues S3 E2: World Liver Day – Join us in celebrating liver health on a global scale

EASL Policy Dialogues S3 E2: World Liver Day – Join us in celebrating liver health on a global scale

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues S3 E3: EASL’s statement: Key asks to the EU for the liver

EASL Policy Dialogues S3 E3: EASL’s statement: Key asks to the EU for the liver

EASL Policy Dialogues
View